Import A-Ret Gel 0.05% Tretinoin Gel, Menarini, 20g — Buy in wholesale FOB from Supplier in India

A-ret Gel 0.05% is a topical retinoid formulation containing 0.5 mg per gram Tretinoin (all-trans retinoic acid), manufactured by Menarini and supplied by GELDIX PHARMACEUTICAL PRIVATE LIMITED from Bhopal, India. The 20-gram tube is a gel-based vehicle, distinct from cream or lotion bases, selected for faster absorption and lower comedogenic potential. The active pharmaceutical ingredient, Tretinoin, is a vitamin A derivative that accelerates epidermal cell turnover and reduces follicular hyperkeratosis. GELDIX lists this as an export-oriented dermatological product suited to pharmaceutical distribution, not cosmetic retail.

The gel vehicle typically employs a hydroalcoholic base with carbomer or hydroxypropyl cellulose as the gelling agent, with pH adjusted to 3.0 to 4.0 for Tretinoin stability and skin penetration. Standard pharmaceutical-grade Tretinoin raw material conforms to USP or BP monograph specifications with assay limits of 90.0 to 110.0 percent. The 0.05 percent concentration is a mid-strength dermatological dose, positioned between the 0.025 percent introductory and 0.1 percent maximum strengths in typical acne treatment protocols. Menarini manufacturing is subject to EU-GMP or equivalent national GMP compliance, though buyers must request the specific site master file and current GMP certificate for the manufacturing location.

This product serves dermatology clinics, hospital pharmacies, licensed wholesale distributors, and government tender programmes requiring retinoid therapy supply. Importers should confirm cold-chain capability, as Tretinoin gel degrades under heat and light exposure, typically requiring storage at 2 to 8 degrees Celsius or as per manufacturer stability data. GELDIX mentions flexible MOQ, FOB and CIF shipping terms, and L/C or T/T payment options, but does not state exact quantities, price per unit, or lead time. Regulatory import licences, product registration, and shelf-life remaining are critical pre-order verifications for pharmaceutical buyers.

GELDIX PHARMACEUTICAL PRIVATE LIMITED is based in Bhopal, India, and operates as an organic-tier, voyage-trust supplier on this platform. The company profile does not disclose founding year, facility size, number of employees, annual revenue, or specific manufacturing versus trading capacity. The response rate is recorded at 0.00 percent with zero average response hours, which indicates that enquiries submitted through this channel may not receive prompt replies.

The listing positions GELDIX as a pharmaceutical exporter with access to Menarini-manufactured Tretinoin gel, but no wholesale distribution licences, drug manufacturing licences, or export authorisations are displayed. No client references, tender awards, or audited financials are mentioned. Buyers must independently verify the company's wholesale drug licence number, whether it holds a valid pharmaceutical export registration, and its cold-chain logistics capability before placing orders. All claims regarding facility standards and regulatory standing should be supported by primary documentation, not assumed from the listing alone.